Antibodies

Antibodies

Primary Antibodies

LIM KINASE 1

B RAF

FGFR2

MEK2

ERK2

PDGF RECEPTOR BETA

Human

Mouse

Rat

Monkey

Dog

WB

IF

IHC

IP

FC

ELISA

Mouse

KO Validated Antibodies

Unconjugated

Biotin

HRP

IgG2a

IgG1

IgG2b

Monoclonal

TrueMAB

Druggable Genome

ES Cell Differentiation/IPS

Protein Kinase

Adult stem cells

Embryonic stem cells

Secreted Protein

Transmembrane

Stem cell - Pluripotency

Pathways in cancer

Prostate cancer

ErbB signaling pathway

Progesterone-mediated oocyte maturation

Fc epsilon RI signaling pathway

Focal adhesion

Endometrial cancer

Non-small cell lung cancer

MAPK signaling pathway

Pancreatic cancer

Fc gamma R-mediated phagocytosis

Cell cycle

Neurotrophin signaling pathway

Bladder cancer

Acute myeloid leukemia

B cell receptor signaling pathway

Calcium signaling pathway

Oocyte meiosis

Adherens junction

Glioma

Insulin signaling pathway

Melanoma

Small cell lung cancer

Tight junction

Colorectal cancer

Regulation of actin cytoskeleton

Chronic myeloid leukemia

Renal cell carcinoma

Vascular smooth muscle contraction

mTOR signaling pathway

Toll-like receptor signaling pathway

p53 signaling pathway

Chemokine signaling pathway

GnRH signaling pathway

Gap junction

T cell receptor signaling pathway

VEGF signaling pathway

Adipocytokine signaling pathway

Apoptosis

Axon guidance

Jak-STAT signaling pathway

Type II diabetes mellitus

Long-term depression

Primary immunodeficiency

Endocytosis

Long-term potentiation

Natural killer cell mediated cytotoxicity

Thyroid cancer

Epithelial cell signaling in Helicobacter pylori infection

Melanogenesis

Prion diseases

TGF-beta signaling pathway

Alzheimer's disease

NOD-like receptor signaling pathway

Amyotrophic lateral sclerosis (ALS)

Cytokine-cytokine receptor interaction

Dorso-ventral axis formation

Leukocyte transendothelial migration

Olfactory transduction

RIG-I-like receptor signaling pathway

1